Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of…

By M. Bookman, K. Darcy, D. Clarke‐Pearson, R. Boothby, I. Horowitz. Journal of Clinical Oncology, 2003

597 citations recorded by the source corpus.